Indoco Remedies Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 532612 |
NSE Symbol : INDOCO |
P/E(TTM) : 35.99 |
ISIN Demat : INE873D01024 |
Div & Yield% : 0.40 |
EPS(TTM) : 10.46 |
Book Value(₹) : 122.22 |
Market Cap(₹Cr) : 3,470.20 |
Face Value(₹) : 2.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 394.22 | 435.14 | 448.38 | 465.24 | 413.19 | 428.05 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 394.22 | 435.14 | 448.38 | 465.24 | 413.19 | 428.05 |
Other Operating Income | 7.21 | 10.35 | 0.67 | 8.15 | 9.69 | -0.59 |
Other Income | 3.52 | 23.78 | 2.93 | 1.12 | 0.41 | 0.49 |
Total Income | 404.95 | 469.27 | 451.98 | 474.51 | 423.29 | 427.95 |
Total Expenditure | 349.86 | 388.13 | 391.96 | 400.97 | 359.97 | 363.29 |
PBIDT | 55.09 | 81.14 | 60.02 | 73.54 | 63.32 | 64.66 |
Interest | 11.88 | 10.91 | 10.03 | 8.10 | 7.78 | 8.64 |
PBDT | 43.21 | 70.23 | 49.99 | 65.44 | 55.54 | 56.02 |
Depreciation | 23.70 | 23.73 | 22.97 | 21.41 | 19.87 | 17.69 |
Tax | 4.73 | 10.46 | 2.24 | 11.51 | 8.55 | 12.35 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -0.17 | -1.52 | 4.77 | -0.62 | 1.18 | 0.61 |
Reported Profit After Tax | 14.95 | 37.56 | 20.01 | 33.14 | 25.94 | 25.37 |
Extra-ordinary Items | 0.00 | 15.29 | -6.07 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 14.95 | 22.27 | 26.08 | 33.14 | 25.94 | 25.37 |
EPS (Unit Curr.) | 1.62 | 4.08 | 2.17 | 3.60 | 2.81 | 2.75 |
EPS (Adj) (Unit Curr.) | 1.62 | 4.08 | 2.17 | 3.60 | 2.81 | 2.75 |
Calculated EPS (Unit Curr.) | 1.62 | 4.07 | 2.17 | 3.60 | 2.81 | 2.75 |
Calculated EPS (Adj) (Unit Curr.) | 1.62 | 4.07 | 2.17 | 3.60 | 2.81 | 2.75 |
Calculated EPS (Ann.) (Unit Curr.) | 6.49 | 16.30 | 8.69 | 14.39 | 11.26 | 11.01 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 6.49 | 16.30 | 8.69 | 14.39 | 11.26 | 11.01 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 18.44 | 18.44 | 18.43 | 18.43 | 18.43 | 18.43 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 13.97 | 18.65 | 13.39 | 15.81 | 15.32 | 15.11 |
PBDTM(%) | 10.96 | 16.14 | 11.15 | 14.07 | 13.44 | 13.09 |
PATM(%) | 3.79 | 8.63 | 4.46 | 7.12 | 6.28 | 5.93 |